Ποια είναι η τιμή για Pharmanutra S.p.A. (PHN)

Η τιμή για Pharmanutra S.p.A. (PHN) είναι $97.03

Ποια είναι η κεφαλαιοποίηση αγοράς για Pharmanutra S.p.A. (PHN)

Η κεφαλαιοποίηση αγοράς για Pharmanutra S.p.A. (PHN) είναι $929.06M

Pharmanutra S.p.A. (PHN) Τιμή και Κεφαλαιοποίηση Αγοράς

Pharmanutra S.p.A. functions as a pharmaceutical and nutraceutical enterprise, focusing on the research, development, design, and marketing of nutritional supplements and medical devices. Its market reach extends across Italy, other parts of Europe, the Middle East, the Far East, and globally. Moreover, the company manufactures and promotes pharmaceuticals, medical devices, over-the-counter (OTC) items, and nutraceuticals specifically for the pediatric population. Furthermore, Pharmanutra is a producer and supplier of raw materials and active ingredients to the food, pharmaceutical, and dietary supplement industries. Its diverse product portfolio features prominent brands like the SiderAL series (including SiderAL Forte, SiderAL Folic, Cardio SiderAL, SiderAL Med), the Cetilar range (Cetilar Crema, Cetilar Patch, Tape), along with ApportAL, UltraMag, Gestalys DHA, Novomega, Bonecal, and DiKappa 2. These products are distributed and sold through a network comprising sales representatives, wholesalers, pharmacies, and para-pharmacies. Established in 2003, the company's base of operations is in Pisa, Italy.

Η τιμή για PHN	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$549,741 $929.06M	NVDA	$5.264T	+566,482.44%
$490,986 $929.06M	AAPL	$4.701T	+505,927.22%
$436,250 $929.06M	GOOG	$4.177T	+449,515.31%
$398,677 $929.06M	MSFT	$3.817T	+410,790.34%
$299,351 $929.06M	AMZN	$2.866T	+308,421.45%

Η τιμή για PHN

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$549,741 $929.06M